Home LiteratureArticle Details
PMID: 7011568 Published · ppublish English Journal Article

Incompatibility properties of Col E1 and pMB1 derivative plasmids: random replication of multicopy replicons.

Cell ·Vol. 23 ·No. 1 ·1981-01-00 ·Pages 229-38

Hashimoto-Gotoh T, Timmis KN

Abstract

The incompatibility properties of Col E1-like plasmids have been examined in Rec+ and RecA- bacteria. Two Col E1- (or two pMB1-) derivative plasmids coreplicated in the same clone for many cell doublings, irrespective of the rec genotype of host bacteria. Their kinetics of segregation were found to be consistent with models that assume a random choice of template molecule for each plasmid replication event, but with models based on a single (master) template molecule per cell. In contrast, minimal coreplication of a Col E1- and a pMB1-derivative plasmid occurred, with the latter type rapidly excluding the former. We suggest here that the pMB1 derivatives, pMB9 and pBR322, are less sensitive than Col E1 derivatives to the putative inhibitor that regulates plasmid replication, due to base sequence differences in their target for the inhibitor, and consider one mechanism whereby the duplication of Col E1-like plasmids might be regulated.

MeSH Terms
Bacterial Proteins/genetics Bacteriocin Plasmids DNA Replication DNA, Bacterial/genetics Escherichia coli/genetics Gene Expression Regulation Plasmids Rec A Recombinases Replicon Transformation, Genetic
Chemicals
Bacterial Proteins DNA, Bacterial Rec A Recombinases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Hashimoto-Gotoh T
Timmis K N
Article Info
Journal
Cell
Abbr.
Cell
ISSN
0092-8674
Published
1981-01-00
Pages
229-38
Language
English
Region
United States
NLM ID
0413066
Subset
IM
Databases
GENBANK
V00270
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com